480PThe safety and efficacy of FOLFOXIRI plus molecular target therapy as a first-line treatment for metastatic colorectal cancer: A multicentre retrospective study. (23rd October 2018) - Ogata, T; Satake, H; Ogata, M; Hatachi, Y; Hamada, M; Yasui, H